Shuai Z. Su

61 Daizong Street
Taian City, 271017, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

An Integrated Cell-Death Program Defines Aggressive Prostate Cancer by Coupling Ezrin to the Hippo-YAP/TAZ Axis.

An Integrated Cell-Death Program Defines Aggressive Prostate Cancer by Coupling Ezrin to the Hippo-YAP/TAZ Axis.

Journal: Annals of surgical oncology
Published: February 13, 2026

A novel prognostic signature based on mitochondrial permeability transition-driven necrosis genes for biochemical recurrence prediction in prostate cancer.

A novel prognostic signature based on mitochondrial permeability transition-driven necrosis genes for biochemical recurrence prediction in prostate cancer.

Journal: Frontiers in oncology
Published: December 25, 2025

Racial/ethnic and sex disparities in mortality among US cancer survivors.

Racial/ethnic and sex disparities in mortality among US cancer survivors.

Journal: Journal of cancer research and clinical oncology
Published: December 11, 2025

Proteomic profiling identifies nucleolin as a U3-interacting protein that inhibits avian leukosis virus replication.

Proteomic profiling identifies nucleolin as a U3-interacting protein that inhibits avian leukosis virus replication.

Journal: Veterinary microbiology
Published: November 27, 2025

Acetylation-mediated regulation of ALV viral proteins: Implications for retroviral inhibition.

Acetylation-mediated regulation of ALV viral proteins: Implications for retroviral inhibition.

Journal: PLoS pathogens
Published: November 12, 2025

C21orf2 as a potential regulator of JAK2/STAT3 signaling in prostate cancer cell proliferation and apoptosis: an exploratory study.

C21orf2 as a potential regulator of JAK2/STAT3 signaling in prostate cancer cell proliferation and apoptosis: an exploratory study.

Journal: BMC cancer
Published: October 28, 2025

Smooth Muscle Disruptive Feature Defines Molecular Subtyping, Risk Stratification, and Metastatic Potential in Prostate Cancer.

Smooth Muscle Disruptive Feature Defines Molecular Subtyping, Risk Stratification, and Metastatic Potential in Prostate Cancer.

Journal: Annals of surgical oncology
Published: July 14, 2025

Interpretable machine learning models based on multi-dimensional fusion data for predicting positive surgical margins in robot-assisted radical prostatectomy: a retrospective study.

Interpretable machine learning models based on multi-dimensional fusion data for predicting positive surgical margins in robot-assisted radical prostatectomy: a retrospective study.

Journal: Frontiers in oncology
Published: July 08, 2025

Loss of biomechanical features reveals smooth muscle disruption and disease progression in prostate cancer.

Loss of biomechanical features reveals smooth muscle disruption and disease progression in prostate cancer.

Journal: Cancer cell international
Published: July 06, 2025

Type III interferons attenuates Th1/Th17 cell pathogenicity and regulates retinal pigment epithelium cells via NLRP1/NLRP3 signaling axis in autoimmune uveitis.

Type III interferons attenuates Th1/Th17 cell pathogenicity and regulates retinal pigment epithelium cells via NLRP1/NLRP3 signaling axis in autoimmune uveitis.

Journal: Genes & diseases
Published: July 03, 2025

Integration of genetic, proteomic, and transcriptomic data identifies therapeutic targets and prognostic biomarkers in bladder cancer.

Integration of genetic, proteomic, and transcriptomic data identifies therapeutic targets and prognostic biomarkers in bladder cancer.

Journal: Translational andrology and urology
Published: June 24, 2025

Nanoparticles co-loaded with bacillus Calmette-Guérin pure protein derivative and doxorubicin for bladder tumor therapy.

Nanoparticles co-loaded with bacillus Calmette-Guérin pure protein derivative and doxorubicin for bladder tumor therapy.

Journal: BMC biotechnology
Published: June 14, 2025
Showing 1-12 of 63

Last Updated: 09/26/2026